FRONTERAS DE LA ONCOLOGÍA MODERNA: ESTRATEGIAS BASADAS EN EL ANÁLISIS MOLECULAR PARA EL CÁNCER METASTÁSICO DE MAMA HR+/HER2− (++)

Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Giuseppe Curigliano, MD, PhD; Nicola Fusco, MD https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010ph?page=1&uac=148436CN&src=mkmcmr_driv_il_mscpedu_261104_12403559_#transcript-download-es CPD Frontiers in Modern Oncology: Molecular-Guided Strategies for HR-Positive/HER2-Negative Metastatic Breast Cancer Authors: Giuseppe Curigliano, MD, PhD; Nicola Fusco, MD https://www.medscape.org/viewarticle/frontiers-modern-oncology-molecular-guided-strategies-hr-2026a10010ph?page=2&uac=148436CN&src=mkmcmr_driv_il_mscpedu_261104_&subtitle-lang-code=es